Management of central retinal vein occlusion

Ophthalmologica

Volumn 217, Issue 3, 2003, Pages 167-188

  Hayreh, Sohan Singh ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Central retinal vein occlusion; Classification; Investigations; Management; Natural history; Therapy; Treatment

Indexed keywords

CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; HISTORY OF MEDICINE; HUMAN; LASER COAGULATION; MEDICAL ASSESSMENT; NEOVASCULARIZATION (PATHOLOGY); REVIEW;

DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; FEMALE; HEALTH PLANNING; HUMANS; ISCHEMIA; MALE; RETINAL NEOVASCULARIZATION; RETINAL VEIN; RETINAL VEIN OCCLUSION; RISK FACTORS; VISUAL ACUITY; VISUAL FIELDS;

EID: 0037236945     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068980     Document Type: Review

References (87)

1. Hayreh SS, Zimmerman MB, Podhajsky P: Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994;117: 429-441.
2. Michel J: Ueber die anatomischen Ursachen von Veraenderungen des Augenhintergrundes bei einigen Allgemeinerkrankungen. Dtsch Arch Klin Med 1878;22:339-345.
3. Hayreh SS: Occlusion of the central retinal vessels. Br J Ophthalmol 1965;49:626-645.
4. Hayreh SS: Pathogenesis of occlusion of the central retinal vessels. Am J Ophthalmol 1971; 72:998-1011.
5. Hayreh SS: So-called 'central retinal vein occlusion'. I. Pathogenesis, terminology, clinical features. Ophthalmologica 1976;172:1-13.
6. Hayreh SS: So-called 'central retinal vein occlusion'. II. Venous stasis retinopathy. Ophthalmologica 1976;172:14-37.
7. Hayreh SS: Central retinal vein occlusion: Differential diagnosis and management. Trans Am Acad Ophthalmol Otolaryngol 1977;83: OP379-OP391.
8. Hayreh SS: Central retinal vein occlusion; in Mausolf FA (ed): The Eye and Systemic Disease, Ed 2. St. Louis, CV Mosby, 1980, pp 223-275.
9. Hayreh SS: Classification of central retinal vein occlusion. Ophthalmology 1983;90:458-474.
10. Hayreh SS, Rojas P, Podhajsky P, Montague P, Woolson RF: Ocular neovascularization with retinal vascular occlusion. III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 1983;90:488-506.
11. Hayreh SS, Klugman MR, Beri M, Kimura AE, Podhajsky P: Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase. Graefes Arch Clin Exp Ophthalmol 1990;228:201-217.
12. Hayreh SS: Retinal vein occlusion. Indian J Ophthalmol 1994;42:109-132.
13. Hayreh SS, Joos KM, Podhajsky PA, Long CR: Systemic diseases associated with non-arteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994;118:766-780.
14. Hayreh SS: Central retinal vein occlusion. Ophthalmol Clin North Am 1998;11:559-590.
15. Hayreh SS, Klugman MR, Podhajsky P, Servais GE, Perkins ES: Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion - a 10-year prospective study. Graefes Arch Clin Exp Ophthalmol 1990;228: 281-296.
16. Hayreh SS, Klugman MR, Podhajsky P, Kolder HE: Electroretinography in central retinal vein occlusion: Correlation of electroretinographic changes with pupillary abnormalities. Graefes Arch Clin Exp Ophthalmol 1989;227: 549-561.
17. Servais GE, Thompson HS, Hayreh SS: Relative afferent pupillary defect in central retinal vein occlusion. Ophthalmology 1986;93:301-303.
18. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology 1995;102: 1434-1444.
19. Zegarra H, Gutman FA, Conforto J: The natural course of central retinal vein occlusion. Trans Am Acad Ophthalmol Otolaryngol 1979; 86:1931-1939.
20. Quinlan PM, Elman MJ, Bhatt AK, Mardesich P, Enger C: The natural course of central retinal vein occlusion. Am J Ophthalmol 1990; 110:118-123.
21. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 1997;115:486-491.
22. Holmin N, Ploman KG: Thrombosis of central vein of retina treated with heparin. Lancet 1938;i:664.
23. Kohner EM, Laatikainen L, Oughton J: The management of central retinal vein occlusion. Ophthalmology 1983;90:484-487.
24. Hayreh SS, Zimmerman MB, Podhajsky PA: Hematologic abnormalities associated with various types of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:180-196.
25. Hansen LL, Wiek J, Wiederholt M: A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol 1989;73:895-899.
26. Wolf S, Arend O, Bertram B, Remky A, Schulte K, Wald KJ, Reim M: Hemodilution therapy in central retinal vein occlusion: One-year results of a prospective randomized study. Graefes Arch Clin Exp Ophthalmol 1994;232: 33-39.
27. Glacet-Bernard A, Zourdani A, Milhoub M, Maraqua N, Coscas G, Soubrane G: Effect of isovolemic hemodilution in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001;239:909-914.
28. Hansen LL, Danisevskis P, Arntz H-R, Hovener G, Wiederholt M: A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation. Br J Ophthalmol 1985;69: 108-116.
29. Hattenbach LO, Wellermann G, Steinkamp GW, Scharrer I, Koch FH, Ohrloff C: Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion. Ophthalmologica 1999;213:360-366.
30. Luckie AP, Wroblewski JJ, Hamilton P, Bird AC, Sanders M, Slater N, Green W: A randomised prospective study of outpatient haemodilution for central retinal vein obstruction. Aust NZ J Ophthalmol 1996;24:223-232.
31. Dodson PM, Galton DJ, Winder AF: Retinal vascular abnormalities in the hyperlipidaemias. Trans Ophthalmol Soc UK 1981;101:17-21.
32. Wiek J, Schade M, Wiederholt M, Arntz HR, Hansen LL: Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution. Br J Ophthalmol 1990; 74:665-669.
33. Hayreh SS: Optic disc vasculitis. Br J Ophthalmol 1972;56:652-670.
34. Jonas JB, Söfker A: Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-427
35. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C: Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109: 920-927.
36. Jonas JB, Kreissig I, Söfker A, Degenring RF: Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol, in press.
37. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E: Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86: 247-248.
38. Jonas JB, Kreissig I, Degenring RF: Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002; 240:782-783.
39. Jonas JB, Kreissig I, Degenring R: Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol, in press.
40. Duke-Elder S, Dobree JH: System of Ophthalmology. Diseases of the Retina. London, Kimpton, 1967, vol 10, pp 101-102.
41. Jonas JB: Concentration of intravitreally injected triamcinolone acetonide in aqueous humour. Br J Ophthalmol 2002;86:1066.
42. Jonas JB, Hayler JK, Sofker A, Panda-Jonas S: Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone. J Glaucoma 2001;10:284-287.
43. Hayreh SS, March W, Phelps CD: Ocular hypotony following retinal vein occlusion. Arch Ophthalmol 1978;96:827-833.
44. Vasco-Posada J: Modification of the circulation in the posterior pole of the eye. Ann Ophthalmol 1972;4:48-59.
45. Hayreh SS: Pathogenesis of Oedema of the Optic Disc (Papilloedema); PhD thesis, University of London, 1965.
46. Hayreh SS: Pathogenesis of oedema of the optic disc. Doc Ophthalmol 1968;24:289-411.
47. Opremcak EM, Bruce RA, Lomeo MD, Ridenour CD, Letson AD, Rehmar AJ: Radial optic neurotomy for central retinal vein occlusion: A retrospective pilot study of 11 consecutive cases. Retina 2001;21:408-415.
48. Hayreh SS: Radial optic neurotomy for central retinal vein occlusion. Retina 2002;22:374-377.
49. Hayreh SS, Vrabec F: The structure of the head of the optic nerve in rhesus monkey. Am J Ophthalmol 1966;61:136-150.
50. Hayreh SS: Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol 1977;95:1553-1565.
51. Hayreh SS: Acute ischemic disorders of the optic nerve: Pathogenesis, clinical manifestations and management. Ophthalmol Clin North Am 1996;9:407-442.
52. Hayreh SS: The blood supply of the optic nerve head and the evaluation of it - myth and reality. Prog Retin Eye Res 2001;20:563-593.
53. Sergott RC, Cohen MS, Bosley TM, Savino PJ: Optic nerve decompression may improve the progressive form of non-arteritic ischemic optic neuropathy. Arch Ophthalmol 1989;107:1743-1754.
54. Hayreh SS: The role of optic nerve sheath fenestration in management of anterior ischemic optic neuropathy. Arch Ophthalmol 1990;108:1063-1064.
55. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA 1995;272:625-632.
56. Cotran RS, Kumar V, Robbins SL: Fate of the thrombus; in Cotran RS, Kumar V, Robbins SL (eds): Robbins' Pathologic Basis of Disease. Philadelphia, Saunders 1989, p 102.
57. Kohner EM, Pettit JE, Hamilton AM, Bulpitt CJ, Dollery CT: Streptokinase in central retinal vein occlusion: A controlled clinical trial. Br Med J 1976;i:550-553.
58. Elman MJ: Thrombolytic therapy for central retinal vein occlusion: Results of a pilot study. Trans Am Ophthalmol Soc 1996;94:471-504.
59. Elman MJ, Raden RZ, Carrigan A: Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 2001;99:219-221.
60. Glacet-Bernard A, Kuhn D, Vine AK, Oubraham H, Coscas G, Soubrane G: Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: A pilot study. Br J Ophthalmol 2000;84:609-613.
61. Paques M, Vallée JN, Herbreteau D, Aymart A, Santiago PY, Campinchi-Tardy F, Payen D, Merlan JJ, Gaudric A, Massin P: Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol 2000;84:1387-1391.
62. Vallée JN, Massin P, Aymard A, Paques M, Herbreteau D, Santiago PY, Losser MR, Gaudric A, Merland JJ: Superselective ophthalmic arterial fibrinolysis with urokinase for recent severe central retinal venous occlusion: Initial experience. Radiology 2000;216:47-53.
63. Lam HD, Blumenkranz MS: Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary and epipapillary adhesions, subretinal peripapillary tissue plasminogen activator injection, and photocoagulation. Am J Ophthalmol 2002;134:609-611.
64. Weiss JN, Bynoe LA: Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249-2257.
65. Hayreh SS: t-PA in CRVO. Ophthalmology 2002;109:1758-1761.
66. Weiss JN, Bynoe LA: t-PA in CRVO. Ophthalmology 2002;109:1761-1763.
67. Richard G, Lerche R-C, Knospe V, Zeumer H: Treatment of retinal arterial occlusion with local fibrinolysis using rTPA. Ophthalmology 1999;106:768-773.
68. Hayreh SS: Retinal arterial occlusion with LIF using rTPA. Ophthalmology 1999;106:1236-1238, 2044.
69. McAllister IL, Constable IJ: Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion. Arch Ophthalmol 1995;113:456-462.
70. McAllister IL, Douglas JP, Constable IJ, Yu DY: Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: Evaluation of the complications and their risk factors. Am J Ophthalmol 1998;126:219-229.
71. Fekrat S, Goldberg MF, Finkelstein D: Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol 1998;116:43-52.
72. Browning DJ, Antoszyk AN: Laser chorioretinal venous anastomosis for nonischemic central retinal vein occlusion. Ophthalmology 1998;105:670-679.
73. Aktan SG, Subasi M, Akbatur H, Or M: Problems of chorioretinal venous anastomosis by laser for treatment of nonischemic central retinal vein occlusion. Ophthalmologica 1998;212:389-393.
74. Browning DJ, Rotberg MH: Vitreous hemorrhage complicating laser-induced chorioretinal anastomosis for central retinal vein occlusion. Am J Ophthalmol 1996;122:588-589.
75. Eccarius SG, Moran MJ, Slingsby JG: Choroidal neovascular membrane after laser-induced chorioretinal anastomosis. Am J Ophthalmol 1996;122:590-591.
76. Luttrull JK: Epiretinal membrane and traction retinal detachment complicating laser-induced chorioretinal venous anastomosis. Am J Ophthalmol 1997;123:698-699.
77. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology 1995;102:1425-1433.
78. Magargal LE, Brown GC, Augsburger JJ, Parrish RK 2nd: Neovascular glaucoma following central retinal vein obstruction. Ophthalmology 1981;88:1095-1101.
79. Magargal LE, Brown GC, Augsburger JJ, Donoso LA: Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. Ophthalmology 1982;89:780-784.
80. Laatikainen L, Kohner EM, Khoury D, Blach RK: Panretinal photocoagulation in central retinal venous occlusion: A randomised controlled clinical study. Br J Ophthalmol 1977;61:741-753.
81. Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group. Am J Ophthalmol 1976;81:383-396.
82. Williamson TH: Central retinal vein occlusion: What's the story? Br J Ophthalmol 1997;81:698-701.
83. Hayreh SS: The CVOS Group M and N Reports. Ophthalmology 1996;103:350-352.
84. Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol 1993;111:1087-1095.
85. Central Vein Occlusion Study Group. The CVOS Group M and N Reports. Ophthalmology 1996;103:353-354.
86. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P: Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001;131:61-77.
87. Ingerslev J: Thrombophilia: A feature of importance in retinal vein thrombosis? Acta Ophthalmol Scand 1999;77:619-621.